200,000+ products from a single source!
sales@angenechem.com
106790-96-9 | Benzamide,N-[2-(diethylamino)ethyl]-4-iodo-
CAS No: 106790-96-9 Catalog No: AG00833S MDL No:
Product Description
Catalog Number:
AG00833S
Chemical Name:
Benzamide,N-[2-(diethylamino)ethyl]-4-iodo-
CAS Number:
106790-96-9
Molecular Formula:
C13H19IN2O
Molecular Weight:
346.2072
IUPAC Name:
N-[2-(diethylamino)ethyl]-4-iodobenzamide
InChI:
InChI=1S/C13H19IN2O/c1-3-16(4-2)10-9-15-13(17)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10H2,1-2H3,(H,15,17)
InChI Key:
HRVWCNMOEFNEON-UHFFFAOYSA-N
SMILES:
CCN(CCNC(=O)c1ccc(cc1)I)CC
Properties
Complexity:
224
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
346.054g/mol
Formal Charge:
0
Heavy Atom Count:
17
Hydrogen Bond Acceptor Count:
2
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
346.212g/mol
Monoisotopic Mass:
346.054g/mol
Rotatable Bond Count:
6
Topological Polar Surface Area:
32.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.6
Literature
| Title | Journal |
|---|---|
| Preparation and biological evaluation of cyclopentadienyl-based 99mTc-complexes [(Cp-R)99mTc(CO)3] mimicking benzamides for malignant melanoma targeting. | Nuclear medicine and biology 20100401 |
| Synthesis and evaluation of novel radioiodinated nicotinamides for malignant melanoma. | Nuclear medicine and biology 20081001 |
| Evaluation of radiolabeled (hetero)aromatic analogues of N-(2-diethylaminoethyl)-4-iodobenzamide for imaging and targeted radionuclide therapy of melanoma. | Journal of medicinal chemistry 20080612 |
| Alkylating benzamides with melanoma cytotoxicity: experimental chemotherapy in a mouse melanoma model. | Melanoma research 20061201 |
| Secondary ion mass spectrometry as a tool for investigating radiopharmaceutical distribution at the cellular level: the example of I-BZA and (14)C-I-BZA. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20051001 |
| [Phase 2 clinical study of 123I-N-(2-diethylaminoethyl)-2-iodobenzamide in the diagnostic of primary and metastatic ocular melanoma]. | Journal francais d'ophtalmologie 20040101 |
| Ultra-structural cell distribution of the melanoma marker iodobenzamide: improved potentiality of SIMS imaging in life sciences. | Biomedical engineering online 20040101 |
| Melanin affinity of N-(2-diethylaminoethyl)-4-iodobenzamide, an effective melanoma imaging agent. | Melanoma research 20020401 |
| Synthesis, characterization and comparative biodistribution study of a new series of p-iodine-125 benzamides as potential melanoma imaging agents. | Nuclear medicine and biology 20011001 |
| Distribution of I-BZA (N-2-diethylaminoethyl-4-iodobenzamide) in grafted melanoma and normal skin: a study by secondary ion mass spectroscopy. | Cellular and molecular biology (Noisy-le-Grand, France) 20010501 |
Related Products
© 2019 Angene International Limited. All rights Reserved.